Literature DB >> 25787077

The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ).

Xinchun Shen1, Gang Xi2, Christine Wai2, David R Clemmons3.   

Abstract

Insulin-like growth factor-binding protein-2 (IGFBP-2) functions coordinately with IGF-I to stimulate cellular proliferation and differentiation. IGFBP-2 binds to receptor tyrosine phosphatase β (RPTPβ), and this binding in conjunction with IGF-I receptor stimulation induces RPTPβ polymerization leading to phosphatase and tensin homolog inactivation, AKT stimulation, and enhanced cell proliferation. To determine the mechanism by which RPTPβ polymerization is regulated, we analyzed the protein(s) that associated with RPTPβ in response to IGF-I and IGFBP-2 in vascular smooth muscle cells. Proteomic experiments revealed that IGF-I stimulated the intermediate filament protein vimentin to bind to RPTPβ, and knockdown of vimentin resulted in failure of IGFBP-2 and IGF-I to stimulate RPTPβ polymerization. Knockdown of IGFBP-2 or inhibition of IGF-IR tyrosine kinase disrupted vimentin/RPTPβ association. Vimentin binding to RPTPβ was mediated through vimentin serine phosphorylation. The serine threonine kinase PKCζ was recruited to vimentin in response to IGF-I and inhibition of PKCζ activation blocked these signaling events. A cell-permeable peptide that contained the vimentin phosphorylation site disrupted vimentin/RPTPβ association, and IGF-I stimulated RPTPβ polymerization and AKT activation. Integrin-linked kinase recruited PKCζ to SHPS-1-associated vimentin in response to IGF-I and inhibition of integrin-linked kinase/PKCζ association reduced vimentin serine phosphorylation. PKCζ stimulation of vimentin phosphorylation required high glucose and vimentin/RPTPβ-association occurred only during hyperglycemia. Disruption of vimetin/RPTPβ in diabetic mice inhibited RPTPβ polymerization, vimentin serine phosphorylation, and AKT activation in response to IGF-I, whereas nondiabetic mice showed no difference. The induction of vimentin phosphorylation is important for IGFBP-2-mediated enhancement of IGF-I-stimulated proliferation during hyperglycemia, and it coordinates signaling between these two receptor-linked signaling systems.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Akt PKB; Insulin-like Growth Factor (IGF); Serine/Threonine Protein Kinase; Vascular Smooth Muscle Cells; Vimentin

Mesh:

Substances:

Year:  2015        PMID: 25787077      PMCID: PMC4416861          DOI: 10.1074/jbc.M114.620237

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Activation of protein kinase C-zeta and phosphatidylinositol 3'-kinase and promotion of macrophage differentiation by insulin-like growth factor-I.

Authors:  Q Liu; W Ning; R Dantzer; G G Freund; K W Kelley
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

2.  Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport.

Authors:  M L Standaert; L Galloway; P Karnam; G Bandyopadhyay; J Moscat; R V Farese
Journal:  J Biol Chem       Date:  1997-11-28       Impact factor: 5.157

3.  Critical role of vimentin phosphorylation at Ser-56 by p21-activated kinase in vimentin cytoskeleton signaling.

Authors:  Qing-Fen Li; Amy M Spinelli; Ruping Wang; Yana Anfinogenova; Harold A Singer; Dale D Tang
Journal:  J Biol Chem       Date:  2006-09-20       Impact factor: 5.157

4.  Silencing of p21-activated kinase attenuates vimentin phosphorylation on Ser-56 and reorientation of the vimentin network during stimulation of smooth muscle cells by 5-hydroxytryptamine.

Authors:  Dale D Tang; Ying Bai; Susan J Gunst
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

5.  Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism.

Authors:  R Rajah; B Valentinis; P Cohen
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

Review 6.  Novel functions of vimentin in cell adhesion, migration, and signaling.

Authors:  Johanna Ivaska; Hanna-Mari Pallari; Jonna Nevo; John E Eriksson
Journal:  Exp Cell Res       Date:  2007-04-14       Impact factor: 3.905

7.  Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.

Authors:  Xinchun Shen; Gang Xi; Laura A Maile; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

8.  Mapping the integrin-linked kinase interactome using SILAC.

Authors:  Iveta Dobreva; Andrew Fielding; Leonard J Foster; Shoukat Dedhar
Journal:  J Proteome Res       Date:  2008-03-10       Impact factor: 4.466

9.  Integrin-linked kinase stabilizes myotendinous junctions and protects muscle from stress-induced damage.

Authors:  Hao-Ven Wang; Ling-Wei Chang; Klara Brixius; Sara A Wickström; Eloi Montanez; Ingo Thievessen; Martin Schwander; Ulrich Müller; Wilhelm Bloch; Ulrike Mayer; Reinhard Fässler
Journal:  J Cell Biol       Date:  2008-03-10       Impact factor: 10.539

10.  Differential targeting of protein kinase C and CaM kinase II signalings to vimentin.

Authors:  M Ogawara; N Inagaki; K Tsujimura; Y Takai; M Sekimata; M H Ha; S Imajoh-Ohmi; S Hirai; S Ohno; H Sugiura
Journal:  J Cell Biol       Date:  1995-11       Impact factor: 10.539

View more
  11 in total

1.  Mesenchymal stem cells suppress cardiac alternans by activation of PI3K mediated nitroso-redox pathway.

Authors:  Prasongchai Sattayaprasert; Drew M Nassal; Xiaoping Wan; Isabelle Deschenes; Kenneth R Laurita
Journal:  J Mol Cell Cardiol       Date:  2016-05-26       Impact factor: 5.000

2.  IRS-1 Functions as a Molecular Scaffold to Coordinate IGF-I/IGFBP-2 Signaling During Osteoblast Differentiation.

Authors:  Gang Xi; Xinchun Shen; Clifford J Rosen; David R Clemmons
Journal:  J Bone Miner Res       Date:  2016-02-20       Impact factor: 6.741

3.  IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1.

Authors:  Ning Dai; Fei Ji; Jason Wright; Liliana Minichiello; Ruslan Sadreyev; Joseph Avruch
Journal:  Elife       Date:  2017-07-28       Impact factor: 8.140

4.  Zanthoxylum alkylamides ameliorate protein metabolism disorder in STZ-induced diabetic rats.

Authors:  Tingyuan Ren; Yuping Zhu; Xuejuan Xia; Yongbo Ding; Jing Guo; Jianquan Kan
Journal:  J Mol Endocrinol       Date:  2017-01-18       Impact factor: 5.098

5.  IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery.

Authors:  Justine Faramia; Zheng Hao; Michael B Mumphrey; R Leigh Townsend; Stéphanie Miard; Anne-Marie Carreau; Mélanie Nadeau; Frédérique Frisch; Elena-Dana Baraboi; Thomas Grenier-Larouche; Christophe Noll; Meng Li; Laurent Biertho; Simon Marceau; Frédéric-Simon Hould; Stéfane Lebel; Christopher D Morrison; Heike Münzberg; Denis Richard; André C Carpentier; André Tchernof; Hans-Rudolf Berthoud; Frédéric Picard
Journal:  Cell Rep Med       Date:  2021-04-20

6.  Midkine is neuroprotective and influences glial reactivity and the formation of Müller glia-derived progenitor cells in chick and mouse retinas.

Authors:  Warren A Campbell; Amanda Fritsch-Kelleher; Isabella Palazzo; Thanh Hoang; Seth Blackshaw; Andy J Fischer
Journal:  Glia       Date:  2021-02-10       Impact factor: 7.452

Review 7.  Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer.

Authors:  Periyasamy Amutha; Thangarajan Rajkumar
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Apr-Jun

8.  Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression.

Authors:  Z Zelenko; E J Gallagher; A Tobin-Hess; V Belardi; R Rostoker; J Blank; Y Dina; D LeRoith
Journal:  Oncogene       Date:  2016-08-29       Impact factor: 9.867

9.  A peptide containing the receptor binding site of insulin-like growth factor binding protein-2 enhances bone mass in ovariectomized rats.

Authors:  Gang Xi; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Bone Res       Date:  2018-08-14       Impact factor: 13.567

Review 10.  Role of Receptor Protein Tyrosine Phosphatases (RPTPs) in Insulin Signaling and Secretion.

Authors:  Julio Sevillano; María Gracia Sánchez-Alonso; Javier Pizarro-Delgado; María Del Pilar Ramos-Álvarez
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.